ArticleActive
Response to Comments: Trigger Point Injections (TPI)
A59656
National Government Services, Inc. (J06)
Effective: April 1, 2024
Updated: December 31, 2025
Policy Summary
The provided document is a response-to-comments article that lists references concerning trigger point injections (TPIs) for conditions such as myofascial pain syndrome, cervicogenic headache, neck pain, and chronic non-malignant musculoskeletal pain. The excerpt contains bibliography and topic references but does not include explicit coverage criteria, limitations, documentation requirements, or frequency limits; extraction of definitive policy criteria requires the full LCD text and/or the complete response document.
Coverage Criteria Preview
Key requirements from the full policy
"Trigger point injections are referenced for treatment of myofascial pain syndrome (myofascial trigger points)."
Sign up to see full coverage criteria, indications, and limitations.